Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-099728·ArriVent BioPharma, Inc.
Schedule 13G ownership disclosure
ArriVent Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 04272N102
Event date: 2025-10-08
- Filing-level shares
- 2,195,014.00
- Percent of class
- 5.4%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 2,195,014.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-099728
- Form type
- SCHEDULE 13G
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Oct 15, 2025
- Reporting period
- Oct 08, 2025
- Description
- Schedule 13G beneficial ownership